A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition. . . . → Read More: Synthetic Bio Company Goes Public in $2.5B Merger
|
|||||
|
       
  |
 Comments are closed  Finance  biotechnology, economics, engineering, entrepreneurs, equity, genomics, investment, IPO, life sciences, merger, pharmaceuticals 
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms. . . . → Read More: AI Drug Discovery Company Acquired in $270M Deal Comments are closed Finance biomedical, biotechnology, cancer, chemistry, engineering, equity, genomics, investment, life sciences, mathematics, merger, physical sciences
GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion. . . . → Read More: Molecular Diagnostics Company Acquired in $1.8B Deal Comments are closed Finance biomedical, biotechnology, engineering, equity, investment, life sciences, medical device, merger, physical sciences, university 
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes. . . . → Read More: Gene-Editing Biotech Acquires DNA Bar Code Company One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, merger, pharmaceuticals, university 
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal Comments are closed Finance biomedical, cancer, equity, Europe, investment, life sciences, merger, pharmaceuticals, U.K. 
Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020. . . . → Read More: 2020 Venture Funds Mixed, Biotech Keeps Sizzling One comment - (Comments are closed) Finance biotechnology, economics, equity, investment, IPO, merger, software, venture capital 
A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis. . . . → Read More: Neuroscience Biotech Acquired in $770M Deal One comment - (Comments are closed) Finance biomedical, biotechnology, equity, Europe, investment, life sciences, merger, pharmaceuticals, psychiatric 
Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk. . . . → Read More: Oral Drug Delivery Company Acquired in $1.8B Deal Comments are closed Finance biomedical, biotechnology, chemistry, equity, Europe, investment, licensing, life sciences, merger, pharmaceuticals, physical sciences 
Nationwide jitters in the U.S. appear to be affecting venture capital activities in the week of the presidential and congressional elections. . . . → Read More: Venture Rounds, IPOs, Mergers Vanish in Election Week One comment - (Comments are closed) Finance economics, entrepreneurs, equity, investment, IPO, merger, statistics, venture capital 
Global drug maker Bayer AG is acquiring the company Asklepios BioPharmaceutical, developer of gene therapies to treat inherited disorders. . . . → Read More: Bayer Gains Gene Therapy Biotech in $4B Deal Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, manufacturing, merger, pharmaceuticals |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||